QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC

Clinical trial NCT07330596 · RECRUITING

Trial details

NCT number: NCT07330596
Sponsor: Anhui Provincial Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2025-10-30
Primary completion: 2028-01-28
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.